MP Biomedicals™ Recombinant SARS-CoV-2 Nucleocapsid Protein (His tag)

Catalog No.	Quantity
MP08L100012	100 μg

Catalog No. MP08L100012 Supplier MP Biomedicals™ Supplier No. 08L100012

Description

Recombinant SARS-CoV-2 Nucleocapsid Protein with his tag is ultra-pure and possesses a high biological activity, which can be applied to a variety of scientific experiments related to SARS-CoV-2 research.

Recombinant SARS-CoV-2 Nucleocapsid Protein with His tag is produced by Baculovirus-Infected Sf9 Cells expression system. The target protein is expressed with sequence (Ser2-Ala419) of SARS-CoV-2 Nucleocapsid protein (Accession #QHD43423.2) fused with a 6×His tag at the N-terminus.

• Eukaryotic (Baculovirus-Infected Sf9 Cells) system-expressed protein
• High bioactivity determined with ELISA
• High purity determined with SDS-PAGE

Specifications

• For Use With (Application): Binding Assay, ELISA, Immune Blocking, Immunoprecipitation, SDS-PAGE, Surface Plasmon Resonance (SPR), Western Blot
• Formulation: Supplied as a 0.22 μm filtered solution in 20 mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH 8.0
• Gene ID (Entrez): 43740575
• Preparation Method: Affinity Chromatography
• Quantity: 100 μg
• Regulatory Status: RUO
• Endotoxin Concentration: < 0.1 EU/μg of the protein by LAL method
• Gene Alias: Nucleocapsid protein; Nucleoprotein; Protein N
• Conjugate: Unconjugated
• Species: SARS-CoV-2
• Protein Tag: N-6xHis
• Content And Storage: -20°C
• Target Species Named: Human, Mouse, Rat
• Expression System: Baculovirus-Infected Sf9 Cells
• Color: Clear
• Purity or Quality Grade: > 97% by SDS-PAGE
• Protein: SARS-CoV-2 Nucleocapsid
• Solubility: Reconstitute it with sterile PBS or 10 mM Tris buffer. Addition of a carrier protein (such as 0.05 to 0.1% BSA) is recommended for long-term storage

For research or further manufacturing use only, not for direct human use.